Wilms tumour 1 peptide vaccine as a cure‐oriented post‐chemotherapy strategy for patients with acute myeloid leukaemia at high risk of relapse
Jun Nakata; Yoshiki Nakae; Manabu Kawakami; Soyoko Morimoto; Daisuke Motooka; Naoki Hosen; Fumihiro Fujiki; Hiroko Nakajima; Kana Hasegawa; Sumiyuki Nishida; Akihiro Tsuboi; Yusuke Oji; Yoshihiro Oka; Atsushi Kumanogoh; Haruo Sugiyama
Author Information: Department of Cancer Immunotherapy
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.